Page last updated: 2024-10-22

amitriptyline and Leishmaniasis, Visceral

amitriptyline has been researched along with Leishmaniasis, Visceral in 2 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research Excerpts

ExcerptRelevanceReference
"Cyclobenzaprine (CBP) is a tricyclic structurally related to the antidepressant amitriptyline, differing only by the presence of a double bond in the central ring."1.46Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice. ( Abengózar, MA; Almeida-Amaral, EE; Andrade-Neto, VV; Barbas, C; Cunha-Júnior, EF; da Costa-Silva, TA; Galisteo Junior, AJ; Lima, ML; Rivas, L; Tempone, AG; Torres-Santos, EC, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lima, ML2
Abengózar, MA2
Torres-Santos, EC2
Borborema, SET1
Godzien, J1
López-Gonzálvez, Á1
Barbas, C2
Rivas, L2
Tempone, AG2
Cunha-Júnior, EF1
Andrade-Neto, VV1
da Costa-Silva, TA1
Galisteo Junior, AJ1
Almeida-Amaral, EE1

Other Studies

2 other studies available for amitriptyline and Leishmaniasis, Visceral

ArticleYear
Energy metabolism as a target for cyclobenzaprine: A drug candidate against Visceral Leishmaniasis.
    Bioorganic chemistry, 2022, Volume: 127

    Topics: Adenosine Triphosphate; Amitriptyline; Animals; Antiprotozoal Agents; Energy Metabolism; Humans; Lei

2022
Cyclobenzaprine Raises ROS Levels in Leishmania infantum and Reduces Parasite Burden in Infected Mice.
    PLoS neglected tropical diseases, 2017, Volume: 11, Issue:1

    Topics: Amitriptyline; Animals; Antiprotozoal Agents; Humans; Interferon-gamma; Interleukin-10; Interleukin-

2017